EFFECTS OF THE BET-INHIBITOR APABETALONE ON CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ACUTE CORONARY SYNDROME, ACCORDING TO PRESENCE OR ABSENCE OF CHRONIC KIDNEY DISEASE. A BETONMACE TRIAL REPORT

Kalantar-Zadeh, K; Ray, KK; Nicholls, SJ; Ginsburg, HN; Buhr, KA; Johansson, J; Kulikowski, E; Toth, PP; Sweeney, M; Schwartz, GG

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020; 35 (): 182